The prophylactic efficacy of TMP-SMX was significantly higher in subgroups with baseline lymphopenia, azotemia, microscopic polyangiitis, or relapsed AAV.

Geographic disparities seen, with greater percentage of cardiovascular deaths attributable to di-2-ethylhexylphthalate exposure for South Asia, Middle East.

Sustainable development efforts such as lowering out-of-pocket health expenses can reduce future prevalence of AMR by 5.1 percent.

(HealthDay News) — The number of kidney transplants performed annually in the United States has increased steadily, but with decreasing allocation efficiency, according to a study published online in ...

Patients with diabetic macular edema treated with intravitreal aflibercept have a significantly higher risk of adverse renal events compared with those treated with ranibizumab.

(HealthDay News) — For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS) are comparable ...

The new initiative will focus on research using the beta-propiolactone vaccine platform. (HealthDay News) — The U.S. Department of Health and Human Services and the National Institutes of Health ...

Illness severity, comorbidities, and prior exposure to antibiotics associated with hospital-onset antimicrobial resistant infections. (HealthDay News) — Hospital-onset antimicrobial-resistant ...

Among patients with diabetic foot ulcer, those with end-stage kidney disease (ESKD) fare worse than those with earlier stages of chronic kidney disease (CKD). Study findings were presented in a poster ...

Sodium bicarbonate has some down sides, but there are suitable alternatives, including increased intake of fruits and vegetables and sodium citrate. Metabolic acidosis is a common yet often overlooked ...

Authors say findings do not support routine hormone use in the perimenopausal and postmenopausal periods. (HealthDay News) — Hormone therapy use is linked to worse bladder health in ...

SGLT-2 inhibitor use, compared with DPP-4 inhibitor use, was associated with a lower incidence of epilepsy among patients with type 2 diabetes. The use of sodium-glucose cotransporter 2 (SGLT-2 ...